Resources

Optimizing IRT for Clinical Supply Management

WHITEPAPER: IRT systems can be a double-edged sword. Set up properly, it can make your clinical supply strategy a breeze to execute. Set up improperly, it can apply additional pressure and stress to a sponsor’s resupply execution

Specialty Medicines Packaging: Keys of the Process from Clinical to Commercial Launch

WHITE PAPER: When pharmaceutical and biopharmaceutical companies engage in new product development, there is a historical tendency to focus on the immediate needs of the clinical phase. As a result, many commercialization-related decisions...

Customs Valuation for IMPs and Clinical Material in the US and Europe

WHITEPAPER: When biotech and pharma companies transport investigational medical products (IMPs) internationally, they are often required to pay import

Clinical Supply Distribution Strategy – Planning & Adapting

WHITEPAPER: A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes. A good

EU Compassionate Use Programs – Where’s My Drug

WHITEPAPER: By its nature, EU compassionate use supply is needed urgently. This means packaging, labeling, and distribution must be executed rapidly and efficiently

European Compassionate Use Programs

WHITEPAPER: Tris Evans, Gavin Morgan, Uday Pathapati discuss what factors need to be considered from a quality, packaging and labeling, logistical and risk management perspective when planning an EU Compassionate Use Program...

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients